ATE14525T1 - Trockene, sterile, gamma-globulin angebundene saeule und verfahren zur herstellung derselben. - Google Patents

Trockene, sterile, gamma-globulin angebundene saeule und verfahren zur herstellung derselben.

Info

Publication number
ATE14525T1
ATE14525T1 AT81110168T AT81110168T ATE14525T1 AT E14525 T1 ATE14525 T1 AT E14525T1 AT 81110168 T AT81110168 T AT 81110168T AT 81110168 T AT81110168 T AT 81110168T AT E14525 T1 ATE14525 T1 AT E14525T1
Authority
AT
Austria
Prior art keywords
globulin
sterile
dry
making
same
Prior art date
Application number
AT81110168T
Other languages
German (de)
English (en)
Inventor
Hiroshi Hayashi
Takao Kiyota
Mitsuru Shibuakawa
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of ATE14525T1 publication Critical patent/ATE14525T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0094—Gaseous substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A61L2/206—Ethylene oxide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
AT81110168T 1980-12-18 1981-12-04 Trockene, sterile, gamma-globulin angebundene saeule und verfahren zur herstellung derselben. ATE14525T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP55178110A JPS57103649A (en) 1980-12-18 1980-12-18 Sterilized gamma-globulin fixing column
EP81110168A EP0054799B1 (en) 1980-12-18 1981-12-04 A dried, sterilized, gamma-globulin-fixed column and a process for preparing the same

Publications (1)

Publication Number Publication Date
ATE14525T1 true ATE14525T1 (de) 1985-08-15

Family

ID=16042821

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81110168T ATE14525T1 (de) 1980-12-18 1981-12-04 Trockene, sterile, gamma-globulin angebundene saeule und verfahren zur herstellung derselben.

Country Status (5)

Country Link
US (1) US4409105A (en, 2012)
EP (1) EP0054799B1 (en, 2012)
JP (1) JPS57103649A (en, 2012)
AT (1) ATE14525T1 (en, 2012)
DE (1) DE3171620D1 (en, 2012)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490290A (en) * 1981-02-26 1984-12-25 Internationale Octrooi Maatschappij "Octropa" B.V. Process for the recovery of immunoglobulins
JPS58146354A (ja) * 1982-02-26 1983-08-31 日機装株式会社 体液浄化器の製造法
EP0103184B1 (en) * 1982-08-12 1990-01-17 Kanegafuchi Chemical Industry Co., Ltd. Activation of biocompatible terpolymers with biologicals whose binding complements are pathological effectors
US4737544A (en) * 1982-08-12 1988-04-12 Biospecific Technologies, Inc. Biospecific polymers
JPS59155259A (ja) * 1983-02-23 1984-09-04 株式会社　ミドリ十字 腫瘍細胞除去用炉過器
US4685900A (en) * 1983-06-01 1987-08-11 Biospecific Technologies, Inc. Therapeutic device
JPS607363A (ja) * 1983-06-27 1985-01-16 Sekisui Chem Co Ltd 抗原もしくは抗体の測定方法
JPS6035263A (ja) * 1983-08-05 1985-02-23 Wako Pure Chem Ind Ltd 不溶性担体に固定化された免疫活性物質の安定化法及び該物質を構成単位として含む生理活性物質測定用試薬
JPS60147650A (ja) * 1984-01-12 1985-08-03 Toshiba Corp 検体からの上澄液生成方法
JPH035793Y2 (en, 2012) * 1985-03-06 1991-02-14
EP0197521B1 (en) * 1985-04-09 1989-08-02 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Immunoglobulin adsorbent and adsorption apparatus
JPS62186940A (ja) * 1986-02-10 1987-08-15 Kanegafuchi Chem Ind Co Ltd リポ蛋白用吸着体
EP0272792B1 (en) * 1986-11-21 1994-09-14 Imre Corporation Antigen-specific removal of circulating immune complexes
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
US4892710A (en) * 1987-07-07 1990-01-09 Bioprobe International, Inc. Cartridge assembly with multi-purpose closure tubing
US5045190A (en) * 1988-11-08 1991-09-03 Carbonell Ruben G Chromatography apparatus
US5468622A (en) * 1990-04-03 1995-11-21 Immunomatrix, Inc. Salt stabilization of antibody-enzyme conjugates heat-dried into paper
ATE232737T1 (de) * 1990-04-16 2003-03-15 Baxter Int Methode zur unschädlichmachung viraler und bakterieller blutverunreinigungen
US5418130A (en) * 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5342752A (en) * 1990-04-16 1994-08-30 Cryopharm Corporation Method of inactivation of viral blood contaminants using acridine deriatives
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
CA2055811A1 (en) * 1991-01-11 1992-07-12 Ross R. Muth Sterilization of growth factors
US6491655B1 (en) * 1991-09-09 2002-12-10 Harvey B. Pollard Methods for treating hemophilia A and B and AIDS and devices used therein
US20040067157A1 (en) * 1993-07-22 2004-04-08 Clearant, Inc. Methods for sterilizing biological materials
US5362442A (en) * 1993-07-22 1994-11-08 2920913 Canada Inc. Method for sterilizing products with gamma radiation
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
CN1209548A (zh) * 1998-06-08 1999-03-03 南开大学 碳化树脂dna免疫吸附剂的制备方法
US20040086420A1 (en) * 2000-03-23 2004-05-06 Macphee Martin J. Methods for sterilizing serum or plasma
US7320757B2 (en) * 2001-01-30 2008-01-22 Kaneka Corporation Body fluid processor enabling direct hemoperfusion
US6682695B2 (en) * 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
US6696060B2 (en) 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
US20030031584A1 (en) * 2001-08-10 2003-02-13 Wilson Burgess Methods for sterilizing biological materials using dipeptide stabilizers
US6946098B2 (en) 2001-08-10 2005-09-20 Clearant, Inc. Methods for sterilizing biological materials
US7252799B2 (en) * 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
US6749851B2 (en) 2001-08-31 2004-06-15 Clearant, Inc. Methods for sterilizing preparations of digestive enzymes
US6783968B2 (en) 2001-09-24 2004-08-31 Clearant, Inc. Methods for sterilizing preparations of glycosidases
US20030185702A1 (en) * 2002-02-01 2003-10-02 Wilson Burgess Methods for sterilizing tissue
US20110091353A1 (en) * 2001-09-24 2011-04-21 Wilson Burgess Methods for Sterilizing Tissue
US20030095890A1 (en) * 2001-09-24 2003-05-22 Shirley Miekka Methods for sterilizing biological materials containing non-aqueous solvents
US20030124023A1 (en) * 2001-12-21 2003-07-03 Wilson Burgess Method of sterilizing heart valves
US20030180181A1 (en) * 2002-02-01 2003-09-25 Teri Greib Methods for sterilizing tissue
US6908591B2 (en) * 2002-07-18 2005-06-21 Clearant, Inc. Methods for sterilizing biological materials by irradiation over a temperature gradient
US20040013562A1 (en) * 2002-07-18 2004-01-22 Wilson Burgess Methods for sterilizing milk.
AU2003303198A1 (en) 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
AT413336B (de) * 2003-09-12 2006-02-15 Mattner Frank Dr Apherese-vorrichtung
DE102006033541A1 (de) * 2006-07-20 2008-01-24 Artemis Control Ag Adsorptives Filtermaterial
EP2201051A1 (en) 2007-08-15 2010-06-30 Isp Investments Inc. Polyvinylamide polymers containing polymerizable functionalities
US8242224B2 (en) * 2007-08-15 2012-08-14 Isp Investments Inc. Polyvinylamide polymers containing polymerizable functionalities
WO2009051265A2 (en) * 2007-10-16 2009-04-23 Fujifilm Corporation Stabilisation of antibodies on hazardous subtance-removing material and method of removing hazardous substances
EP2237804B1 (en) * 2007-12-21 2013-04-10 GE Healthcare Bio-Sciences AB Method for sterilization of chemically activated solid support materials
CN103893850A (zh) * 2012-12-31 2014-07-02 于杰 改进型血液灌流器

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH453269A4 (en, 2012) * 1968-03-29 1973-01-31
US3946105A (en) * 1969-12-18 1976-03-23 Kowa Company, Ltd. Preparation of anti-α1-fetoglobulin
US3857931A (en) * 1971-02-01 1974-12-31 Hoffmann La Roche Latex polymer reagents for diagnostic tests
JPS554417B2 (en, 2012) * 1975-03-11 1980-01-30
CH641689A5 (en) * 1976-10-28 1984-03-15 Asahi Chemical Ind Process for preparing a protein adsorbent
DE2827109C2 (de) * 1977-06-24 1986-10-30 Asahi Kasei Kogyo K.K., Osaka Verfahren und Vorrichtung zur Abtrennung von organischen Verbindungen von Plasmaproteinen des Blutes
US4264449A (en) * 1977-09-21 1981-04-28 American National Red Cross Antibody-specific solid phase immunoadsorbent, preparation thereof, and antibody purification therewith
DE2840655C2 (de) * 1978-09-19 1982-06-16 Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG Apparatebau KG, 6380 Bad Homburg Vorrichtung zur Blutentgiftung
JPS5598117A (en) * 1979-01-17 1980-07-25 Chemo Sero Therapeut Res Inst Purification of gamma-globulin derivative
US4384954A (en) * 1980-04-16 1983-05-24 Kuraray Co., Ltd. Column for adsorption of blood proteins

Also Published As

Publication number Publication date
EP0054799A3 (en) 1983-03-23
US4409105A (en) 1983-10-11
DE3171620D1 (en) 1985-09-05
JPS57103649A (en) 1982-06-28
EP0054799A2 (en) 1982-06-30
JPS645010B2 (en, 2012) 1989-01-27
EP0054799B1 (en) 1985-07-31

Similar Documents

Publication Publication Date Title
ATE14525T1 (de) Trockene, sterile, gamma-globulin angebundene saeule und verfahren zur herstellung derselben.
MX9203370A (es) Desulfatohirudina y composiciones farmaceuticas que la contienen.
ATE253631T1 (de) Eine thrombin-blutfraktion zur verwendung in einem medizinischen verfahren
ATE21046T1 (de) Verfahren zur absorption von schwefeldioxid.
ATE2271T1 (de) 4-(substituierte thiazolyl)-3-hydroxy-3-pyrrolin2,5-dion-verbindungen, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzung.
ATE4168T1 (de) 2-phenyl-1,2-benzisoselenazol-3(2h)-one enthaltende pharmazeutische zubereitungen und ihre anwendung.
DE3881720D1 (de) Geraet zur lagerung und behandlung operativ gewonnener venenstuecke.
ATE9350T1 (de) Tricyclische cytosinderivate zur verwendung in arzneimitteln und verfahren zu ihrer herstellung.
PT71408A (de) Verfahren zur herstellung von 1-alkadien-2,4-yl-2-hidroxymethyl-3,4,5-trimydroxypiperidinen mit wirkung uber die kohlehydraten und/oder fettwechsel und von diesen verbindungen enthaltenden pharmazeutischen und/oder tierartzleichen praparaten
ATE29026T1 (de) Sulfonylharnstoff-derivate, verfahren zur herstellung und pharmazeutische zusammenstellungen die sie enthalten.
ATE110269T1 (de) Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung.
ATE24282T1 (de) Verfahren zur herstellung von pharmazeutischen und kosmetischen dispersionen.
DE59304087D1 (de) Placentaextrakt und Verfahren zu seiner Herstellung
JPS5668654A (en) Novel carbamate* its manufacture and medicine containing it
ATE4216T1 (de) 3-hydrocarbylthio-2-acyloxypropyl 2trimethylammonioethyl phosphate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DK0499679T3 (da) Terapeutisk middel til diabetisk gangræn
ATE3546T1 (de) Tetrahydroisochinolin-derivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen zur verwendung bei der vorbeugung und behandlung von erhoehtem blutdruck.
ATE9063T1 (de) Prothrombin enthaltende therapeutische zusammensetzungen und verfahren zur herstellung enzymatisch aktiver blutgerinnungsfaktoren aus prothrombin enthaltenden blutfraktionen.
ATE5796T1 (de) Pharmazeutische zusammensetzung mit gehalt an l- alpha-methyl-3,4-dihydroxyphenylalanin und salicylamid zur behandlung hohen blutdrucks.
NO163654C (no) Mikrobobleforloeper i steril, injiserbar enhetsdoseringsform, fremgangsmaate til fremstilling av en vandig suspensjonav mikrobobler og anvendelse av mikrobobleforloeperen for injisering i blodstroemmen hos et levende vesen.
ATE3851T1 (de) Monochlorcitronensaeurederivate, diese enthaltende pharmazeutische praeparate und verfahren zur herstellung dieser derivate.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties